Clinical Trial: Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848659) titled 'Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants' on Sept. 09.

Brief Summary: This is a study to evaluate the pharmacodynamic effects, safety, tolerability, and pharmacokinetics of HBS-104 in acutely sleep-deprived healthy adult participants.

Study Start Date: Aug. 28

Study Type: INTERVENTIONAL

Condition: Sleep Deprivation

Intervention: DRUG: HBS-104

Immediate-release tablets for oral use

DRUG: Placebo

Matching placebo tablet

Recruitment Status: RECRUITING

Sponsor: Harmony Biosciences Management, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....